← Eichor
Condition: Episodic Migraine Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Episodic Migraine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
Phase 3 · 6 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05484349Trial Designs for Evaluating Migraine Treatment
NA · 2 location(s) · University of Aarhus · NCT06617832i-NEED: NEw migrainE Drugs Database
Phase N/A · 2 location(s) · IRCCS San Raffaele Roma · NCT07103694Vitamin K2 Supplementation in Adult Episodic Migraine
NA · 1 location(s) · Sola Aoun Bahous, M.D. Ph.D. · NCT05943457Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
NA · 1 location(s) · University of Seville · NCT07694063Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Phase 2 · 6 location(s) · St. Olavs Hospital · NCT06248671Biochemical Profiling of Migraine Patients
Phase N/A · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT06549270PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE
Phase N/A · 1 location(s) · IRCCS Centro Neurolesi Bonino Pulejo · NCT07268768A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase 2 · 166 location(s) · Ipsen · NCT06625060Efficacy of Nerve Blocks for Episodic Migraine
Phase 2 · 1 location(s) · Mayo Clinic · NCT05734625Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine
Phase N/A · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT06882122Migraine Attack Pain Phase Prediction Study
Phase N/A · 1 location(s) · Fundación de Investigación Biomédica - Hospital Universitari · NCT06459635Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments
Phase N/A · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT06562400CGRP Inhibition, Autonomic Function, and Migraine
Phase N/A · 1 location(s) · Medical University of Vienna · NCT04628429Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT07518069Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine
NA · 1 location(s) · Abilion Medical Systems AB · NCT07279623Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Preve
Phase N/A · 36 location(s) · AbbVie · NCT06603558High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological M
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06938178Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06674772The RECLAIM Study.
NA · 11 location(s) · Salvia BioElectronics · NCT06450444A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Phase 3 · 70 location(s) · H. Lundbeck A/S · NCT05164172Treatment of Episodic Migraine With AURICular Neuromodulation
NA · 3 location(s) · Hôpital Européen Marseille · NCT06623188Idebenone for the Preventive Treatment of Migraine
Phase 3 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04151472Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Phase N/A · 26 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07159750A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · 65 location(s) · H. Lundbeck A/S · NCT05897320Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration
NA · 2 location(s) · The Hong Kong Polytechnic University · NCT05690737A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · 108 location(s) · Merz Therapeutics GmbH · NCT07018700Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine
Phase 3 · 1 location(s) · Tsai, Chueh-Yi, MD · NCT07496034EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
Phase N/A · 1 location(s) · IRCCS San Raffaele Roma · NCT05570149A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants
Phase 3 · 98 location(s) · AbbVie · NCT05711394
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.